Review Article
Traditional Uses, Chemical Constituents, and Biological Activities of Bixa orellana L.: A Review
Table 3
Biological activities of extracts of annatto in American countries.
| Country biological activity | Part used | Type of extract | Organism tested | Model tested | Dose used | Activity | References |
| Argentina | | | | | | | | Antibacterial | LE | EtOH | Bacillus subtilis | In vitro | 5 mg/mL | Inactive | [70] | | | | Escherichia coli | In vitro | 5 mg/mL | Inactive | [70] | | | | Micrococcus luteus | In vitro | 5 mg/mL | Inactive | [70] | | | | Pseudomonas aeruginosa | In vitro | 5 mg/mL | Inactive | [70] | | | | Staphylococcus aureus | In vitro | 5 mg/mL | Inactive | [70] | Antifungal | LE | EtOH | Aspergillus niger | In vitro | 5 mg/mL | Inactive | [70] | | | | Candida albicans | In vitro | 5 mg/mL | Inactive | [70] | Antiviral | SE | EtOH | Virus Herpes simplex 1 | Cell culture | 0.78 mg/mL | Inactive | [71] | Insecticidal | AP | MeOH | Insect | Sitophilus oryzae | 5% | Inactive | [71] | Brazil | | | | | | | | Antimalarial | SE | CHCl3 | Mouse | Plasmodium berghei | 100 mg/kg | Inactive | [26] | Antioxidant | SE | EtOH | In vitro | DPPH assay | 0.1 g L−1 | Active | [6] | Insect repellent | SE | Petr. eth | Hamster | Lutzomyia longipalpis | 1 g/L | Active | [72] | | SE | EtOH | Mosquito | Aedes aegypti | 18.2 mg/mL | Active | [6] | Molluscicidal | SE | EtOH | Conch | Biomphalaria glabrata | 10,000 ppm | Inactive | [73] | Mutagenic | | Powder | Mouse | Bone marrow cells | 10,670 ppm | Inactive | [67] | Toxicity | SE | Powder | Rat | In vivo | 500 mg/kg | Inactive | [74] | Antileishmanial | LE/RO | EtOH | Leishmania amazonensis | In vitro | 0,12–2,5 mg/mL | Active | [75] | Antileishmanial | SE | OE | Leishmania amazonensis | In vitro | 10/50/100/500/1000 g/mL | Active | [76] | Hyperlipidemia | SE | H2O | Mouse | In vitro | 400 and 800 mg/kg | Active | [77] | Colombia | | | | | | | | Snakebite | LE | EtOH | Mouse | Bothrops atrox | LD50 > 260 g/animal | Active | [29] | Costa Rica | | | | | | | | Anti-inflammatory | RO | EtOH | Rat | Paw edema/carrageenan | 100 mg/kg | Inactive | [78] | Cuba | | | | | | | | Positive inotropic effect | AP | H2O | Guinea pig | Isolated atrium | 320 L | Inactive | [79] | Antimalarial | SE | | Plasmodium gallinaceum/falciparum | In vivo/in vitro | 500 mg/kg | Active | [80] | Cytotoxic | SE | EtOH | Tumor cells | In vitro | 3,9–250 mg/mL | Active | [81] | Ecuador | | | | | | | | Antifungal | LE | MeOH | Aspergillus niger | In vitro | 10 mg/disk | Inactive | [82] | | | | Candida albicans | In vitro | 10 mg/disk | Inactive | [82] | | | | Cryptococcus neoformans | In vitro | 10 mg/disk | Inactive | [82] | | | | Fusarium oxysporum | In vitro | 10 mg/disk | Inactive | [82] | | | | Neurospora crassa | In vitro | 10 mg/disk | Inactive | [82] | | | | Penicillium purpurogenum | In vitro | 10 mg/disk | Inactive | [82] | | | | Trichophyton mentagrophytes | In vitro | 10 mg/disk | Active | [82] | Guatemala | | | | | | | | Antibacterial | LE | Various | Escherichia coli | In vitro | 50 L/disk | Inactive | [83] | | | | Pseudomonas aeruginosa | In vitro | MIC > 10 mg/mL | Inactive | [83] | | | | Salmonella typhi | In vitro | MIC > 10 mg/mL | Inactive | [83] | | | | Shigella dysenteriae | In vitro | 50 L | Inactive | [83] | | | | Staphylococcus aureus | In vitro | MIC > 10 mg/mL | Inactive | [83] | Antifungal | LE | H2O | Aspergillus flavus | In vitro | MIC > 10 mg/mL | Inactive | [84] | | | | Candida albicans | In vitro | MIC > 10 mg/mL | Inactive | [84] | | | | Microsporum gypseum | In vitro | MIC > 10 mg/mL | Inactive | [84] | Antigonorrheal | LE | EtOH | Neisseria gonorrhea | In vitro | 50 μL/disk | Active | [32] | Antitrypanosomal | LE | EtOH | Trypanosoma cruzi | In vitro | MIC > 1 mg/mL | Inactive | [83] | Cytotoxic | LE | H2O | Crustacean | Artemia salina | LC50 > 1,000 ppm | Inactive | [83] | Inhib. of platelet aggregation | SE | / | In vitro | Thrombin aggregation | IC50 0.795 mg/mL | Inactive | [35] | Hawaii | | | | | | | | Contraceptive | RO | / | Mouse | / | 0.2 mL/animal | Inactive | [85] | Jamaica | | | | | | | | Hypoglycemic | SE | CHCl3 | Dog | | 1 g | Active | [39] | | | H2O | Dog | | 200 mL/animal | Active | [39] | Antioxidant | SE | EtOH | In vitro | In vitro | 0.25 and 2.5 g/mL | Active | [86] | Mexico | | | | | | | | Allergenic | SE | Oil | Human | | 25 μL/ person | Active | [87] | Paraguay | | | | | | | | Insecticidal | SE | Petr. ether | Insect | Rhodnius neglectus | 50 μg | Inactive | [42] | Puerto Rico | | | | | | | | Molluscicidal | TP | H2O | Conch | Lymnaea cubensis | LD100 > 1 M ppm | Inactive | [88] | Dominican Republic | | | | | | | | Cytotoxic | SE | EtOH | Cell culture | Molt 4 cells | 200 g/mL | Inactive | [89] | Trinidad and Tobago | | | | | | | | Antibacterial | SE | EtOAc | Escherichia coli | In vitro | 1,000 g/mL | Inactive | [90] | | | | Pseudomonas aeruginosa | In vitro | 1,000 g/mL | Inactive | [90] | USA | | | | | | | | Anticonvulsant | RA | EtOH | Mouse | Seizures/electroshock | 100 mg/kg | Inactive | [91] | | | | Rat | Seizures/pentylenetetrazole | 400 mg/kg | Inactive | [91] | Antimalarial | SE | CHCl3 | Chicken | Plasmodium gallinaceum | 388 mg/kg | Inactive | [92] | Mutagenic | SE | MeOH | Salmonella typhimurium | | 100 mg/plaque | Inactive | [93] | | | H2O | In vitro | Placental trophoblasts | 100 mg/plaque | Inactive | [93] | Hypotensive | RA | EtOH | Rat | | 50 mg/kg | Active | [93] | Toxicity | RA | H2O | Mouse | | LD50 > 700 mg/kg | Inactive | [92] |
|
|
LE: leaf; AP: aerial part; TP: total plant; RO: root; SE: seed; /: not given; LD50: 50% lethal dose; IC50: concentration that inhibits 50% of the effect; MIC: minimum inhibitory concentration.
|